Daily palonosetron is superior to ondansetron in the prevention of delayed chemotherapy-induced nausea and vomiting in patients with acute myelogenous leukemia

Gloria N. Mattiuzzi, Jorge E. Cortes, Deborah A. Blamble, B. Nebiyou Bekele, Lianchun Xiao, Maria Cabanillas, Gautam Borthakur, Susan O'Brien, Hagop Kantarjian

Research output: Contribution to journal › Article › peer-review

33 Scopus citations

Fingerprint

Dive into the research topics of 'Daily palonosetron is superior to ondansetron in the prevention of delayed chemotherapy-induced nausea and vomiting in patients with acute myelogenous leukemia'. Together they form a unique fingerprint.

Medicine & Life Sciences